Literature DB >> 9665053

Requisite role of cardiac myocytes in coronary alpha1-adrenergic constriction.

C P Tiefenbacher1, D V DeFily, W M Chilian.   

Abstract

BACKGROUND: Alpha-adrenergic activation in vivo causes constriction of coronary arterioles, but, paradoxically, in vitro these microvessels do not contract to this stimulus. We hypothesized that cardiac myocytes have a requisite role in alpha1-adrenergic coronary arteriolar constriction through the release of myocyte-derived contractile factor(s). METHODS AND
RESULTS: Administration of the alpha1-adrenergic agonist phenylephrine did not constrict isolated coronary arterioles, but constriction was observed to supernatant obtained from phenylephrine-treated cardiac myocytes. Constriction to the supernatant was blocked by administration of an endothelin-A antagonist to the microvessel preparation or an alpha-adrenergic antagonist to the myocytes and was augmented after administration of an adenosine antagonist. Administration of phenylephrine to the myocytes increased endothelin-1 levels in the supernatant, but only to subthreshold concentrations.
CONCLUSIONS: Cardiac myocytes have a requisite role in constriction of coronary resistance vessels to alpha1-adrenergic stimuli, which may be mediated by endothelin-1 and other unidentified myocyte-derived vasoconstrictors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665053     DOI: 10.1161/01.cir.98.1.9

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

2.  Vasodilation Responses to Non-Selective α-Adrenergic Blockage of Coronary Bypass Grafts in Diabetic and Non-Diabetic Patients: In Vitro Study.

Authors:  Selami Gurkan; Ozcan Gur; Demet Ozkaramanli Gur; Semil Selcen Gocmez; Turan Ege
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-09-30       Impact factor: 1.520

3.  Cold-acclimation leads to differential regulation of the steelhead trout (Oncorhynchus mykiss) coronary microcirculation.

Authors:  Isabel A S F Costa; Travis W Hein; A K Gamperl
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-02-25       Impact factor: 3.619

4.  Mitochondrial DNA integrity and function are critical for endothelium-dependent vasodilation in rats with metabolic syndrome.

Authors:  Takahiko Kiyooka; Vahagn Ohanyan; Liya Yin; Yuh Fen Pung; Yeong-Renn Chen; Chwen-Lih Chen; Patrick T Kang; James P Hardwick; June Yun; Danielle Janota; Joanna Peng; Christopher Kolz; Giacinta Guarini; Glenn Wilson; Inna Shokolenko; Donte A Stevens; William M Chilian
Journal:  Basic Res Cardiol       Date:  2022-01-17       Impact factor: 12.416

5.  Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation.

Authors:  Vahagn Ohanyan; Liya Yin; Raffi Bardakjian; Christopher Kolz; Molly Enrick; Tatevik Hakobyan; John Kmetz; Ian Bratz; Jordan Luli; Masaki Nagane; Nadeem Khan; Huagang Hou; Periannan Kuppusamy; Jacqueline Graham; Frances Kwan Fu; Danielle Janota; Moses O Oyewumi; Suzanna Logan; Jonathan R Lindner; William M Chilian
Journal:  Circ Res       Date:  2015-07-29       Impact factor: 17.367

6.  Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage.

Authors:  Giacinta Guarini; Takahiko Kiyooka; Vahagn Ohanyan; Yuh Fen Pung; Mario Marzilli; Yeong Renn Chen; Chwen Lih Chen; Patrick T Kang; James P Hardwick; Christopher L Kolz; Liya Yin; Glenn L Wilson; Inna Shokolenko; James G Dobson; Richard Fenton; William M Chilian
Journal:  Basic Res Cardiol       Date:  2016-04-04       Impact factor: 17.165

7.  Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography.

Authors:  Ornella E Rimoldi; Angela J Drake-Holland; Mark I M Noble; Paolo G Camici
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-02       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.